A tissue-engineered small-diameter arterial graft would be of benefit to patients requiring
vascular reconstructive procedures. Our objective was to produce a tissue-engineered …

Small diameter (< 6 mm) vascular grafts are in large demand for coronary and peripheral
bypass procedures. Although synthetic grafts have been developed, tissue-based vascular …

Introduction Cardiovascular disease, including coronary artery and peripheral vascular
pathologies, is the leading cause of mortality in the United States and Western countries …

OBJECTIVE: Various tissue-engineered vascular grafts have been studied to overcome the
clinical disadvantages of conventional prostheses. Previous tissue-engineered vascular …

Objective Autologous grafts are used to repair atherosclerotic cardiovascular diseases;
however, many patients lack suitable donor graft tissue. Recently, tissue engineering …

The large number of coronary artery bypass procedures necessitates development of off-the-
shelf vascular grafts that do not require cell or tissue harvest from patients. However …

The performance of completely biological, decellularized engineered allografts in a sheep
model was evaluated to establish clinical potential of these unique arterial allografts. The 4 …

BACKGROUND: Arterial bypass graft implantation remains the primary therapy for patients
with advanced cardiovascular disease; however, there is no available synthetic small …

Vascular bypass grafting is a commonly performed procedure for ischemic heart disease
and peripheral vascular disease. However, approximately one in fourteen patients do not …

Background. Prosthetic grafts commonly used for vascular reconstruction are limited to
synthetics and cross-linked tissue grafts. Within these devices, graft infections are common …